CLEMSON, S.C. & BERLIN--(BUSINESS WIRE)--Elastrin is a biotechnology startup leveraging a platform technology to develop therapeutics...

A new approach to preventing the most severe outcomes of lung diseases, including COVID-19, has been developed by Elastrin Therapeutics Inc.

Clemson University researchers published pre-clinical proof of reversing in lab animals the leading cause of cardiovascular events in...

Elastrin's Chief Scientific Officer Prof. Naren Vyavahare was granted USD 2.2 million from the National Institutes of Health to advance...

The South Carolina Research Authority (SCRA) has granted Elastrin $25.000 in financial support through its Academic Start-up Assistance...

Elastrin Therpapeutics has won the 2018 Xi´an International Entrepreneuship Competition held in Hamburg October 19, 2018 and was selected...